BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 35680252)

  • 1. Randomised, pragmatic, waitlist controlled trial of cannabis added to prescription opioid support on opioid dose reduction and pain in adults with chronic non-cancer pain: study protocol.
    Jashinski J; Grossman E; Quaye A; Cather C; Potter K; Schoenfeld DA; Evins AE; Gilman JM
    BMJ Open; 2022 Jun; 12(6):e064457. PubMed ID: 35680252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Text messaging intervention to support patients with chronic pain during prescription opioid tapering: protocol for a double-blind randomised controlled trial.
    Gholamrezaei A; Magee MR; McNeilage AG; Dwyer L; Jafari H; Sim AM; Ferreira ML; Darnall BD; Glare P; Ashton-James CE
    BMJ Open; 2023 Oct; 13(10):e073297. PubMed ID: 37879692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating acceptability and feasibility of a mobile health intervention to improve self-efficacy in prescription opioid tapering in patients with chronic pain: protocol for a pilot randomised, single-blind, controlled trial.
    Magee M; Gholamrezaei A; McNeilage AG; Dwyer L; Sim A; Ferreira M; Darnall B; Glare P; Ashton-James C
    BMJ Open; 2022 Apr; 12(4):e057174. PubMed ID: 35473742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility study of a Behavioural Intervention for Opioid Reduction (BIOR) for patients with chronic non-cancer pain in primary care: a protocol.
    Poole HM; Frank B; Begley E; Woods A; Ramos-Silva A; Merriman M; McCulough R; Montgomery C
    BMJ Open; 2023 Jan; 13(1):e065646. PubMed ID: 36657771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing a support programme for opioid reduction for people with chronic non-malignant pain: the I-WOTCH randomised controlled trial protocol.
    Sandhu HK; Abraham C; Alleyne S; Balasubramanian S; Betteley L; Booth K; Carnes D; Furlan AD; Haywood K; Iglesias Urrutia CP; Lall R; Manca A; Mistry D; Nichols VP; Noyes J; Rahman A; Seers K; Shaw J; Tang NKY; Taylor S; Tysall C; Underwood M; Withers EJ; Eldabe S
    BMJ Open; 2019 Aug; 9(8):e028937. PubMed ID: 31399456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription Opioid Taper Support for Outpatients With Chronic Pain: A Randomized Controlled Trial.
    Sullivan MD; Turner JA; DiLodovico C; D'Appollonio A; Stephens K; Chan YF
    J Pain; 2017 Mar; 18(3):308-318. PubMed ID: 27908840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of medical cannabis licensure with prescription opioid receipt: A population-based, individual-level retrospective cohort study.
    Goedel WC; Macmadu A; Shihipar A; Moyo P; Cerdá M; Marshall BDL
    Int J Drug Policy; 2022 Feb; 100():103502. PubMed ID: 34695720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
    Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-Time Monitoring of Cannabis and Prescription Opioid Co-Use Patterns, Analgesic Effectiveness, and the Opioid-Sparing Effect of Cannabis in Individuals With Chronic Pain.
    Mun CJ; Nordeck C; Goodell EMA; Vandrey R; Zipunnikov V; Dunn KE; Finan PH; Thrul J
    J Pain; 2022 Nov; 23(11):1799-1810. PubMed ID: 35817255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical Marijuana and Opioids (MEMO) Study: protocol of a longitudinal cohort study to examine if medical cannabis reduces opioid use among adults with chronic pain.
    Cunningham CO; Starrels JL; Zhang C; Bachhuber MA; Sohler NL; Levin FR; Minami H; Slawek DE; Arnsten JH
    BMJ Open; 2020 Dec; 10(12):e043400. PubMed ID: 33376181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study.
    Campbell G; Hall WD; Peacock A; Lintzeris N; Bruno R; Larance B; Nielsen S; Cohen M; Chan G; Mattick RP; Blyth F; Shanahan M; Dobbins T; Farrell M; Degenhardt L
    Lancet Public Health; 2018 Jul; 3(7):e341-e350. PubMed ID: 29976328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leveraging policy to reduce chronic opioid use by educating and empowering community dwelling adults: a study protocol for the TAPERING randomized controlled trial.
    Turner JP; Caetano P; Tannenbaum C
    Trials; 2019 Jul; 20(1):412. PubMed ID: 31288859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing the default dispense quantity for new opioid analgesic prescriptions: study protocol for a cluster randomised controlled trial.
    Bachhuber MA; Nash D; Southern WN; Heo M; Berger M; Schepis M; Cunningham CO
    BMJ Open; 2018 Apr; 8(4):e019559. PubMed ID: 29678969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tapering of prescribed opioids in patients with long-term non-malignant pain (TOPIO)-efficacy and effects on pain, pain cognitions, and quality of life: a study protocol for a randomized controlled clinical trial with a 12-month follow-up.
    Henrik G; Patrik M; Anders H; Ulf J; Marcelo RF; Åsa R
    Trials; 2021 Jul; 22(1):503. PubMed ID: 34321058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of a Multicenter Randomized Controlled Trial comparing the effectiveness of shared decision making versus motivational interviewing plus cognitive behavioral therapy for voluntary opioid tapering: The INSPIRE study protocol.
    Edlund MJ; Thomas SM; Wagner LK; Thompson JE; Wu LT; Dolor RJ; Chelminski PR; Ives TJ; Archer KR; Dewey CM; Sullivan MD; McCormack LA;
    Contemp Clin Trials; 2024 Feb; 137():107410. PubMed ID: 38092285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studies.
    Noori A; Miroshnychenko A; Shergill Y; Ashoorion V; Rehman Y; Couban RJ; Buckley DN; Thabane L; Bhandari M; Guyatt GH; Agoritsas T; Busse JW
    BMJ Open; 2021 Jul; 11(7):e047717. PubMed ID: 34321302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Effectiveness of Cognitive Behavioral Therapy for Chronic Pain and Chronic Pain Self-Management within the Context of Voluntary Patient-Centered Prescription Opioid Tapering: The EMPOWER Study Protocol.
    Darnall BD; Mackey SC; Lorig K; Kao MC; Mardian A; Stieg R; Porter J; DeBruyne K; Murphy J; Perez L; Okvat H; Tian L; Flood P; McGovern M; Colloca L; King H; Van Dorsten B; Pun T; Cheung M
    Pain Med; 2020 Aug; 21(8):1523-1531. PubMed ID: 31876947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult Medical Cannabinoid Use and Changes in Prescription Controlled Substance Use.
    Williams AR; Mauro CM; Feng T; Waples J; Martins SS; Haney M
    Cannabis Cannabinoid Res; 2023 Oct; 8(5):933-941. PubMed ID: 35486854
    [No Abstract]   [Full Text] [Related]  

  • 20. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.